PURMX Therapeutics

Developer of a silver bullet and nucleic acid drug intended for malignant pleural mesothelioma. The company creates innovative nucleic acid drugs to save patients suffering from intractable diseases a...

Healthcare
Hiroshima, Japan
Founded 2021
9 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$6.6M
Last Round
N/A

Get the full picture

Create a free account to unlock PURMX Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required